Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach of reprogramming recombinases
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach of reprogramming recombinases. The company is applying its proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing.